Pyxis Oncology PYXS
NASDAQ PYXS
$1.68 -0.03 (-1.46%)
As of: Oct 23, 2026 · 2:50 PM EDT

Pyxis Oncology (PYXS) Price to Sales (2024 - 2026)

Updated

Pyxis Oncology's Price to Sales was 13.78 in Q2 2026, down 43.0% from 24.19 a year earlier.

Analysis

Pyxis Oncology (PYXS) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Price to Sales at Pyxis Oncology came in at 5.20, down 10.2% from FY2024.

  • In earlier years, Price to Sales was 5.79 in FY2024.
  • Quarterly Price to Sales has moved between 5.20 (Q4 2025) and 48.93 (Q3 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,124.59 Bn 1,093.18 Bn 19.71 Bn
2 Johnson & Johnson 634.91 Bn 554.77 Bn 17.30 Bn
3 AbbVie 505.42 Bn 478.53 Bn 12.70 Bn
4 Merck 357.53 Bn 311.91 Bn 12.21 Bn
5 Novartis Ag 289.90 Bn 253.89 Bn 11.24 Bn
6 Astrazeneca 264.89 Bn 238.58 Bn 12.86 Bn
7 Amgen 237.79 Bn 193.19 Bn 7.24 Bn
8 Gilead Sciences 194.74 Bn 168.94 Bn 6.22 Bn
9 Pfizer 171.08 Bn 117.73 Bn 10.94 Bn
10 Pyxis Oncology 107.51 Mn -157.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.78
Dec 31, 2025 5.20
Sep 30, 2025 48.93
Jun 30, 2025 24.19
Dec 31, 2024 5.79
API Access

Pyxis Oncology Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=PYXS&period=max&api_key=YOUR_API_KEY